War, Morality, and MDMA: A Conversation with an Anonymous Military Psychologist
In a continuation of our first interview with an anonymous military psychologist and MDMA therapy recipient, we look to the future implications of MDMA therapy in the military, and discuss the broader moral questions and imperatives raised by this kind of treatment...
Uplifting a New Face & Voice of Cannabis: A Happy 4/20 with Safon Floyd of EstroHaze
How do you make your mark in a cannabis industry that gives little visibility to people who look like you? For Safon Floyd of Brooklyn, NY, the answer was evident: create your own narrative. Floyd is the co-founder of EstroHaze, a black women-owned cannabis media...
“Discover who you truly are.” Albert Hofmann’s Bicycle Day and A Critical Look at LSD
This year on April 19, Adam Rahman of Fairfax, VA is commemorating 76 years to the day that Albert Hofmann first tested 250 micrograms of LSD on himself. Hofmann rode his bicycle home from his laboratory in Basel, Switzerland, before embarking on a frightening...
“I Think I Can Leave Afghanistan in the Past”: Interview with a Military Psychologist about MDMA Therapy for PTSD
The subject of this interview is an anonymous military psychologist and Afghanistan war veteran. In addition to his role as a psychologist helping soldiers, many of whom have post traumatic stress disorder, he himself dealt with years of severe PTSD and suicidal...
Why Is the Cannabis Industry Struggling to Build Social Equity in the City of Angels? An Interview with Kristen Lovell of the Social Impact Center, Los Angeles
On Friday March 15, 2019 cannabis activists protested in Austin, Texas outside South by Southwest (SXSW) as former U.S. House Speaker John Boehner presented on the cannabis industry with Acreage Holdings C.E.O. Kevin Murphy. They also spoke out against MedMen CEO Adam...
“Our lawmakers don’t talk to their constituents.” An Interview with New Mexico Activist Monique Chavez on Why Pot Legalization Failed In Her State
On March 16, 2019, the New Mexico state legislature took important steps towards improving access to cannabis. They included separate measures to decriminalize personal possession of cannabis, expand the existing medical marijuana program, and increase the rights of...
FDA Approves Ketamine-Derived Treatment for Depression, But How Are People Really Using It? A Conversation with Kellye Greene of New York DanceSafe
On March 5, 2019, the FDA approved Spravato (esketamine), an intranasal spray for treatment-resistant depression. The drug is chemically very similar to generic ketamine, which is used around the world as a reliable anaesthetic in both human and veterinary surgery. It...
Study Finds 5-MeO-DMT Effective in Relieving Depression and Anxiety
Anxiety and depression are common mental health conditions that negatively impact one’s quality of life and increase the risk for developing a variety of chronic physical ailments. Therapists have used various intervention methods to try and treat these conditions,...
The European Psychedelic Renaissance: Interview with Dr. Henrik Jungaberle
Dr. Henrik Jungaberle is the founder and executive director of MIND European Foundation for Psychedelic Science. In this conversation we discuss the cultural climate in Europe pertaining to psychedelics, efforts and resistance to mainstreaming psychedelics, what MIND...
Art, Ecological Awareness, and Femininity: Interview with David Jay Brown and Rebecca Ann Hill
In this interview we continue our conversation with Rebecca Ann Hill and David Jay Brown, authors of the new book Women of Visionary Art, and discuss the rise of women and the importance of ecological awareness in the context of visionary art and psychedelic use. To...
